Overview
News
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$34.2M
5 rounds on record
Latest round
$5M
Venture round · Sep 2026 · this month
Team
14
US Form 5500 (plan participants) · Dec 2025 · +8% in a year
The money's age
Fresh money
0 months since the last round · not hiring
Momentum
35/100
in the news, fresh money
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Sep 8 Raised a round Venture round $5M Nov 15, 2024 Raised a round Venture round $8.9M · SEC Form D Dec 3, 2021 Raised a round Venture round $8.5M · SEC Form D Feb 27, 2020 Raised a round Venture round $5.9M · SEC Form D Nov 1, 2018 Raised a round Venture round $5.8M · SEC Form D
Funding rounds
RoundDateAmountInvestorsSource
Venture round Sep 2026 $5M Four Major New US Partnerships morningstar.com
Venture round Nov 2024 $8.9M — SEC Form D
Venture round Dec 2021 $8.5M — SEC Form D
Venture round Feb 2020 $5.9M — SEC Form D
Venture round Nov 2018 $5.8M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Dermasensor, Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Cody SimmonsExecutive Officer, DirectorSEC Form D
Cristiane BenvenutoExecutive OfficerSEC Form D
Similar startupsby what they do, their industry and backers
Value-based care, at the point of care. The world's leading AI-powered physician enablement platform.
Coherence11-50 employees
Coherence pioneers therapeutic neurotechnology to manage cancer from inside the body—transforming it from a terminal illness into a…
VexevVenture round $8.6M · 1 mo ago • Founded 2019 • 51-200 employees
Vexev is a Sydney medical technology company founded in 2019 that automates vascular ultrasound imaging. Its robotic scanner produces…
Anemo Labs51-200 employees
We develop highly selective polymer-based sensors to detect gas VOCs in the ppb range, in real-time. We combine custom hardware with…
AI driven digital health solutions. Empower your customers with personalized health care.
Leash Bio11-50 employees
We're transforming drug design with a rich dataset built by screening millions of compounds against thousands of protein to generate…

Overview

An AI-powered device helping physicians detect skin cancer at the point of care, with 96% sensitivity across all three common skin cancers. Request a demo.

News

Blog 16 days ago
Real-World DermaSensor Results in Primary Care
/ Structure only. No colours, sizes or weights on text, everything inherits the site's typography. The only colour values are panel backgrounds, the callout rule, accordion dividers and button fills. NOTE: this style block lives in PART 1 only. It applies
Read more
Report
News Pulse 2.0 20 days ago
DermaSensor Raises $5 Million To Expand AI Skin Cancer Detection Platform And U.S. Partnerships
DermaSensor has raised more than $5 million in new financing, including a $4 million Series B extension from institutional and strategic investors and more than $1 million raised through a community investment round on Wefunder.
Read more
Report
Blog 2 months ago
Can AI Replace a Dermatologist? The Role of AI in Skin Cancer Care
/ Structure only. No colours, sizes or weights on text, everything inherits the site's typography. The only colour values are panel backgrounds, the callout rule, accordion dividers and button fills. / / Images: the theme crops figure images with object-f
Read more
Report
Blog 3 months ago
Closing the Gap: How Primary Care Can Reduce Missed Skin Cancers with DermaSensor
Every May during Skin Cancer Awareness Month, patient questions about moles and spots surge in primary care. The timing is a useful reminder of a year-round challenge: skin cancers that slip past visual assessment in a short primary care visit. Most patie
Read more
Report
Blog 4 months ago
Publications 2026
The post Publications 2026 appeared first on DermaSensor.
Read more
Report
Blog 1 year ago
Publications 2025, Sage Journals: Primary Care Physician Use of Elastic Scattering Spectroscopy on Skin Lesions Suggestive of Skin Cancer
The post Publications 2025, Sage Journals: Primary Care Physician Use of Elastic Scattering Spectroscopy on Skin Lesions Suggestive of Skin Cancer appeared first on DermaSensor.
Read more
Report
Blog 1 year ago
Publications 2025, Sage Journals: DERM-SUCCESS FDA Pivotal Study: A Multi-Reader Multi-Case Evaluation of Primary Care Physicians' Skin Cancer Detection Using AI-Enabled Elastic Scattering Spectroscopy
The post Publications 2025, Sage Journals: DERM-SUCCESS FDA Pivotal Study: A Multi-Reader Multi-Case Evaluation of Primary Care Physicians' Skin Cancer Detection Using AI-Enabled Elastic Scattering Spectroscopy appeared first on DermaSensor.
Read more
Report
Show more news

People

Cody Simmons
Executive Officer, Director
Cristiane Benvenuto
Executive Officer
Christopher Dewey
Director
David Matlin
Director
Maurice Ferre
Director
Ivan Delevic
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Wilmington United States
HQ
200-500 est. staff

Financials

Total raised
$34.2M
Latest round
Venture - Series Unknown
Funding rounds
5
Funding rounds
Round Announced Amount
Venture - Series Unknown 2026 $5M Details
Venture - Series Unknown 2024 $8.9M Details
Venture - Series Unknown 2021 $8.5M Details
Venture - Series Unknown 2020 $5.9M Details
Venture - Series Unknown 2018 $5.8M Details